PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsMicafungin
Mycamine(micafungin)
Micafungin, Mycamine (micafungin) is a small molecule pharmaceutical. Micafungin was first approved as Mycamine on 2005-03-16. It is used to treat candidemia and mycoses in the USA. It has been approved in Europe to treat candidiasis.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
infectionsD007239
signs and symptoms pathological conditionsD013568
Trade Name
FDA
EMA
Micafungin, Mycamine (discontinued: Micafungin)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Micafungin sodium
Tradename
Company
Number
Date
Products
MYCAMINEAstellas PharmaN-021506 RX2005-03-16
2 products, RLD, RS
MICAFUNGIN IN SODIUM CHLORIDE 0.9%BaxterN-216142 RX2023-09-29
3 products, RLD, RS
MICAFUNGINEndoN-212156 RX2021-06-16
2 products, RLD, RS
Show 1 discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
micafunginANDA2025-01-20
micafungin in sodium chlorideNew Drug Application2025-03-07
micafungin sodiumANDA2022-07-28
mycamineNew Drug Application2024-12-27
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
candidemiaEFO_1001282D058387—
mycoses—D009181B35-B49
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
J: Antiinfectives for systemic use
— J02: Antimycotics for systemic use
— J02A: Antimycotics for systemic use
— J02AX: Other antimycotics for systemic use in atc
— J02AX05: Micafungin
HCPCS
Code
Description
J2247
Injection, micafungin sodium (par pharm) not thereapeutically equivalent to j2248, 1 mg
J2248
Injection, micafungin sodium, 1 mg
Clinical
Clinical Trials
70 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
CandidiasisD002177—B372363—14
MycosesD009181—B35-B492133211
CandidemiaD058387EFO_1001282—2132—8
Invasive candidiasisD058365EFO_1001283B372231—8
Invasive fungal infectionsD000072742————1236
AspergillosisD001228EFO_0007157B44—3—3—6
NeutropeniaD009503—D70———213
Invasive pulmonary aspergillosisD055744—B44.0—1—2—3
InfectionsD007239EFO_0000544———1113
LeukemiaD007938—C95—1—1—2
Show 14 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Oral candidiasisD002180EFO_0007406B37.0——2——2
Communicable diseasesD003141————1—12
Liver transplantationD016031EFO_0010682———1——1
FungemiaD016469—B49——1——1
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
MeningitisD008581EFO_0000584G03—1———1
Fungal meningitisD016921EFO_1000942——1———1
Acute diseaseD000208———1———1
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
NeoplasmsD009369—C801————1
Bone marrow transplantationD016026——1————1
Immunocompromised hostD016867—D84.91————1
CandidaD002175——1————1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
FeverD005334—R50.9————11
Febrile neutropeniaD064147——————11
HyperthermiaD000084462——————11
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameMicafungin
INNmicafungin
Description
Micafungin is a cyclic hexapeptide echinocandin antibiotic which exerts its effect by inhibiting the synthesis of 1,3-beta-D-glucan, an integral component of the fungal cell wall. It is used as the sodium salt for the treatment of invasive candidiasis, and of aspergillosis in patients who are intolerant of other therapy. It has a role as an antiinfective agent. It is an echinocandin and an antibiotic antifungal drug.
Classification
Small molecule
Drug classantifungal antibiotics (undefined group)
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
CCCCCOc1ccc(-c2cc(-c3ccc(C(=O)N[C@H]4C[C@@H](O)[C@@H](O)NC(=O)[C@@H]5[C@@H](O)[C@@H](C)CN5C(=O)[C@H]([C@H](O)CC(N)=O)NC(=O)[C@H]([C@H](O)[C@@H](O)c5ccc(O)c(OS(=O)(=O)O)c5)NC(=O)[C@@H]5C[C@@H](O)CN5C(=O)[C@H]([C@@H](C)O)NC4=O)cc3)no2)cc1
Identifiers
PDB—
CAS-ID235114-32-6
RxCUI—
ChEMBL IDCHEMBL457547
ChEBI ID600520
PubChem CID477468
DrugBankDB01141
UNII IDR10H71BSWG (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 7,555 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
4,302 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use